These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31162154)

  • 1. A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder.
    Biederman J; Fried R; DiSalvo M; Woodworth KY; Biederman I; Noyes E; Faraone SV; Perlis RH
    J Clin Psychopharmacol; 2019; 39(4):351-356. PubMed ID: 31162154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings.
    Fried R; DiSalvo M; Kelberman C; Adler A; McCafferty D; Woodworth KY; Green A; Biederman I; Faraone SV; Biederman J
    J Psychopharmacol; 2020 Aug; 34(8):883-890. PubMed ID: 32077768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel digital health intervention to improve patient engagement to stimulants in adult ADHD in the primary care setting: Preliminary findings from an open label study.
    Biederman J; Fried R; DiSalvo M; Driscoll H; Green A; Biederman I; Woodworth KY; Faraone SV
    Psychiatry Res; 2020 Sep; 291():113158. PubMed ID: 32559669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescription.
    Biederman J; Fried R; DiSalvo M; Woodworth KY; Biederman I; Driscoll H; Noyes E; Faraone SV; Perlis RH
    Psychopharmacology (Berl); 2020 Sep; 237(9):2835-2843. PubMed ID: 32591937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study.
    Biederman J; Fried R; DiSalvo M; Storch B; Pulli A; Woodworth KY; Biederman I; Faraone SV; Perlis RH
    Psychiatr Serv; 2019 Oct; 70(10):874-880. PubMed ID: 31242830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.
    Perwien A; Hall J; Swensen A; Swindle R
    J Manag Care Pharm; 2004; 10(2):122-9. PubMed ID: 15032561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
    Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
    JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
    Lachaine J; Beauchemin C; Sasane R; Hodgkins PS
    Postgrad Med; 2012 May; 124(3):139-48. PubMed ID: 22691908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Manag Care Pharm; 2007 Sep; 13(7):570-7. PubMed ID: 17874863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to stimulants in adult ADHD.
    O'Callaghan P
    Atten Defic Hyperact Disord; 2014 Jun; 6(2):111-20. PubMed ID: 24604104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
    Lachaine J; Sikirica V; Mathurin K
    BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.